Results 121 to 130 of about 99,289 (260)

Performing Large‐Scale Genetic Analysis in the Bleeding Disorders Community

open access: yesHaemophilia, EarlyView.
ABSTRACT Inherited bleeding disorders encompass a diverse group of conditions caused by genetic defects affecting coagulation factors, fibrinogen, von Willebrand factor, or platelet function. Despite major advances in quantitative and functional laboratory assays, a substantial diagnostic gap remains, particularly in patients with mild or atypical ...
Anna R. Blankstein   +6 more
wiley   +1 more source

Comparison of the HemoScreen Point‐Of‐Care Haematology Analyser With Sysmex XN, Beckman Coulter DxH 560 and HORIBA Yumizen H550 in Patients With Abnormal Blood Counts

open access: yesInternational Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction HemoScreen is a portable point‐of‐care testing (POCT) haematology analyser capable of measuring 20 complete blood count (CBC) parameters, including a 5‐part leukocyte differential, from venous and capillary blood. This study compared selected CBC and white blood cell (WBC) differential parameters obtained using HemoScreen with ...
Katarína Hradská   +13 more
wiley   +1 more source

Prognostic implications of right ventricular to pulmonary artery uncoupling in cardiac amyloidosis

open access: yesFrontiers in Cardiovascular Medicine
BackgroundRight ventricular–pulmonary arterial (RV–PA) uncoupling in cardiac amyloidosis (CA) has been underexplored, with focus mainly on tricuspid annular plane systolic excursion (TAPSE)/pulmonary artery systolic pressure (PASP).
Aiste Monika Jakstaite   +22 more
doaj   +1 more source

Primary localized conjunctival amyloidosis: A case report with a ten-year follow-up period

open access: yes, 2008
Juan Carlos Mesa-Gutiérrez, Tomás Martí Huguet, Noemí Barnils Garcia, Jorge Arruga GinebredaDepartment of Ophthalmology, Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat, Barcelona ...
Jorge Arruga Ginebreda   +3 more
core  

Systemic reactive (AA) amyloidosis in the course of common variable immunodeficiency

open access: yes, 2010
Patients with primary immunodeficiencies (PID) are currently at low risk for the development of systemic reactive AA amyloidosis. A patient with common variable immunodeficiency and nephrotic syndrome was referred to our Clinic from a Nephrology unit ...
Peralta M. M.   +10 more
core   +1 more source

Role of FibroScan in evaluating hepatic involvement in systemic amyloidosis: a single‐centre prospective pilot study

open access: yesInternal Medicine Journal, EarlyView.
Abstract Background Amyloidosis encompasses a group of diseases characterised by extracellular deposition of misfolded protein fibrils, potentially leading to organ dysfunction. Liver involvement occurs via direct amyloid infiltration, common in immunoglobulin light chain (AL) amyloidosis, or congestive hepatopathy, more typical in transthyretin (ATTR)
M Tang   +9 more
wiley   +1 more source

Atrial fibrillation in the setting of cardiac amyloidosis - A review of the literature.

open access: yes
Cardiac amyloidosis (CA) is related to the aggregation of insoluble fibrous deposits of misfolded proteins within the myocardium. Transthyretin amyloidosis (ATTR) and immunoglobulin light-chain amyloidosis are the main forms of CA.
Letsas, Konstantinos P   +11 more
core   +1 more source

Feasibility, Safety, and Efficacy of Pulsed Field Ablation for Ventricular Arrhythmias: Insights From a Large Health System Registry in the United States

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Background Pulsed field ablation (PFA) is an emerging non‐thermal ablation modality with proven safety in atrial arrhythmia ablation. However, data on its performance for ventricular arrhythmias (VA) remain limited. Objective To evaluate the feasibility, safety, and efficacy of PFA for complex VA in a multicenter real‐world US registry ...
Narut Prasitlumkum   +22 more
wiley   +1 more source

A new staging system for hereditary transthyretin amyloidosis in the era of specific amyloidosis therapies

open access: yesESC Heart Failure
Objectives Currently, there are two prognosis staging systems validated for transthyretin amyloidosis (ATTR). We sought to develop a new staging system dedicated to hereditary transthyretin amyloidosis (ATTRv) patients on specific treatments. Methods and
Gabriela Neculae   +7 more
doaj   +1 more source

Clinical trials portfolio and regulatory outcomes of ixazomib in multiple myeloma: A systematic review and meta‐analysis

open access: yes
British Journal of Haematology, EarlyView.
Veer Shah   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy